Intellia Therapeutics Inc (NTLA)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account
Sell

$9.56

Buy

$9.65

arrow-up$0.26 (+2.83%)

Intellia Therapeutics Inc is a gene editing company focused on the development of proprietary, potentially curative therapeutics utilizing a biological tool known as the CRISPR/Cas9 system.
Prices updated at 22 May 2025, 11:22 EDT
| Prices minimum 15 mins delay
|
Prices in USD
$9.57 - $9.02
$28.18 - $5.90
-
979.90m
-
-
3,564
1.26
2,545,936.19
1.82
102.03m
US45826J1051
-5.23
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.